|
|
| | Desthiazolylmethyl ritonavir Basic information |
| Product Name: | Desthiazolylmethyl ritonavir | | Synonyms: | Ritonavir EP IMP L;(2S)-N-(((1S)-1-benzyl-2-((4S,5S)-4-benzyl-2-oxo-1,3-oxazolidin-5-yl)ethyl)-2-((((2-isopropyl-1,3-thiazol-4-yl)methyl)N-methyl-amino)carbonyl)amino)-3-methylbutanamide;(2S)-3-Methyl-2-[[[Methyl[[2-(1-Methylethyl)-4-thiazolyl]Methyl]aMino]carbonyl]aMino]-N-[(1S)-1-[[(4S,5S)-2-oxo-4-(phenylMethyl)-5-oxazolidinyl]Methyl]-2-phenylethyl]-butanaMide;(S)-N-((S)-1-((4S,5S)-4-benzyl-2-oxooxazolidin-5-yl)-3-phenylpropan-2-yl)-2-(3-((2-isopropylthiazol-4-yl)methyl)-3-methylureido)-3-methylbutanamide;RitonavirEP ImpurityL;Ritonavir Impurity 12(Ritonavir EP Impurity L);Ritonavir EP Impurity L(BP Impurity L);Butanamide, 3-methyl-2-[[[methyl[[2-(1-methylethyl)-4-thiazolyl]methyl]amino]carbonyl]amino]-N-[(1S)-1-[[(4S,5S)-2-oxo-4-(phenylmethyl)-5-oxazolidinyl]methyl]-2-phenylethyl]-, (2S)- | | CAS: | 256328-82-2 | | MF: | C33H43N5O4S | | MW: | 605.79 | | EINECS: | | | Product Categories: | Anti-virals;Inhibitors;Intermediates & Fine Chemicals;Non-nucleoside Reverse Transcriptase;Pharmaceuticals;Anti-viral Compounds;Anti-virals, Inhibitors, Non-nucleoside Reverse Transcriptase, Pharmaceuticals, Intermediates & Fine Chemicals | | Mol File: | 256328-82-2.mol |  |
| | Desthiazolylmethyl ritonavir Chemical Properties |
| Melting point | 65-69°C | | Boiling point | 874.0±65.0 °C(Predicted) | | density | 1.185±0.06 g/cm3(Predicted) | | storage temp. | Refrigerator | | solubility | Chloroform (Slightly), DMSO (Slightly, Sonicated), Methanol (Slightly) | | form | Solid | | pka | 12.40±0.46(Predicted) | | color | White to Off-White |
| | Desthiazolylmethyl ritonavir Usage And Synthesis |
| Chemical Properties | Foam | | Uses | Desthiazolylmethyl Ritonavir (Ritonavir EP Impurity L) is an analogue of the selective HIV protease inhibitor Ritonavir (R535000). It is a COVID19-related research product. |
| | Desthiazolylmethyl ritonavir Preparation Products And Raw materials |
|